Telouet SA

About Telouet SA

Telouet SA is associated with Mehdi El Glaoui, a healthcare executive and board member of THERACLION. Within the French medtech company, he contributes to governance and strategic oversight for a business focused on high-intensity focused ultrasound therapies, particularly non-invasive solutions for varicose vein treatment and other medical applications. His role on the board is best understood as one of long-term strategic support, value creation, and governance discipline. Mehdi El Glaoui’s background is rooted in pharmaceuticals and healthcare leadership. A Doctor of Pharmacy, he held senior executive responsibilities as Chairman and Chief Executive Officer of Laboratoires Cassenne, and later of Wyeth Laboratories, where he led organizations facing strong regulatory, industrial, and commercial demands. He subsequently became Chairman of Louis Dreyfus Commodities in Geneva, before broadening his career toward board mandates and investment-related roles in several companies linked to health, innovation, and business development. He is particularly valued for combining operational leadership experience with board-level judgment. That dual perspective enables him to bring a structured view on strategy, international expansion, financing, and clinical development. At THERACLION, his presence on the board supports a significant phase of transformation for the company, including the industrialization of its offering, commercial acceleration, and a stronger profile with investors and strategic partners. Mehdi El Glaoui is also recognized for his understanding of innovative healthcare environments and for his ability to support technology-driven business models with strong growth potential. His career, spanning leadership in established pharmaceutical groups and involvement in more entrepreneurial projects, makes him a relevant director for a listed company in a scaling phase. In the French listed-company ecosystem, Telouet SA is therefore linked to a director with substantial experience in governance, strategy, and long-term development.